While there has been an increase in stroke-related illness reported with COVID-19, a new study finds that there was a global decline in the volume of stroke hospitalizations, the administration of clot-busting drugs (intravenous thrombolysis/IVT), and inter-facility IVT transfers between primary and comprehensive stroke centers. Further, medical centers with higher COVID19 inpatient volumes experienced steeper declines.